| Autor: |
Maidorn M; a Institute of Neuro- and Sensory Physiology , University Medical Center Göttingen , Göttingen , Germany.; b Center for Biostructural Imaging of Neurodegeneration (BIN) , University of Göttingen Medical Center , Göttingen , Germany., Olichon A; c Inserm, UMR 1037-CRCT , Toulouse , France.; d Université Toulouse III-Paul Sabatier , Toulouse , France., Rizzoli SO; a Institute of Neuro- and Sensory Physiology , University Medical Center Göttingen , Göttingen , Germany.; b Center for Biostructural Imaging of Neurodegeneration (BIN) , University of Göttingen Medical Center , Göttingen , Germany., Opazo F; a Institute of Neuro- and Sensory Physiology , University Medical Center Göttingen , Göttingen , Germany.; b Center for Biostructural Imaging of Neurodegeneration (BIN) , University of Göttingen Medical Center , Göttingen , Germany. |
| Abstrakt: |
Synaptic vesicle fusion (exocytosis) is a precisely regulated process that entails the formation of SNARE complexes between the vesicle protein synaptobrevin 2 (VAMP2) and the plasma membrane proteins Syntaxin 1 and SNAP-25. The sub-cellular localization of the latter two molecules remains unclear, although they have been the subject of many recent investigations. To address this, we generated two novel camelid single domain antibodies (nanobodies) specifically binding to SNAP-25 and Syntaxin 1A. These probes penetrated more easily into samples and detected their targets more efficiently than conventional antibodies in crowded regions. When investigated by super-resolution imaging, the nanobodies revealed substantial extra-synaptic populations for both SNAP-25 and Syntaxin 1A, which were poorly detected by antibodies. Moreover, extra-synaptic Syntaxin 1A molecules were recruited to synapses during stimulation, suggesting that these are physiologically-active molecules. We conclude that nanobodies are able to reveal qualitatively and quantitatively different organization patterns, when compared to conventional antibodies. |
